Network pharmacology analysis to explore the pharmacological mechanism of effective Chinese medicines in treating metastatic colorectal cancer using meta …
Y Zhu, J Yu, K Zhang, Y Feng, K Guo… - The American Journal …, 2021 - World Scientific
The role of traditional Chinese medicine (TCM) on treatment of metastatic colorectal cancer
(mCRC) remains controversial, and its active components and potential targets are still …
(mCRC) remains controversial, and its active components and potential targets are still …
[HTML][HTML] Has the COVID-19 pandemic caused upshifting in colorectal cancer stage?
JH Lim, WY Lee, SH Yun, HC Kim, YB Cho… - Annals of …, 2021 - ncbi.nlm.nih.gov
Purpose Coronavirus disease 2019 (COVID-19) has affected many parts of daily life and
healthcare, including cancer screening and diagnosis. The purpose of this study was to …
healthcare, including cancer screening and diagnosis. The purpose of this study was to …
Impact of bevacizumab on clinical outcomes and its comparison with standard chemotherapy in metastatic colorectal cancer patients: a systematic review and meta …
T Naz, A Rehman, A Shahzad, MF Rasool… - … Policy and Practice, 2024 - Taylor & Francis
Background Advances in targeted therapies have expanded the treatment options for
colorectal cancer (CRC), allowing for more tailored and effective approaches to managing …
colorectal cancer (CRC), allowing for more tailored and effective approaches to managing …
[HTML][HTML] Use of FOLFOXIRI Plus Bevacizumab and Subsequent Therapies in Metastatic Colorectal Cancer: An Age-Stratified Analysis
ZP Vassilev, X Fan, J Xu, H Ostojic, A Barzi - Clinical Colorectal Cancer, 2024 - Elsevier
Background Treatment recommendations for metastatic colorectal cancer (mCRC) do not
differ by age group; nevertheless, aggressive multi-agent chemotherapy comprising …
differ by age group; nevertheless, aggressive multi-agent chemotherapy comprising …
[PDF][PDF] 贝伐珠单抗联合卡培他滨维持对晚期结肠癌患者预后的影响
胡丽霞， 汪超 - 河北医学, 2024 - hbyxzzs.cn
目的: 探究贝伐珠单抗联合卡培他滨维持对晚期结肠癌患者预后的影响. 方法: 收集2017 年1
月至2019 年1 月期间我院101 例晚期结肠癌患者的病例资料, 所有患者均接受5 …
月至2019 年1 月期间我院101 例晚期结肠癌患者的病例资料, 所有患者均接受5 …
СПОСОБ КОМБИНИРОВАННОГО ЛЕЧЕНИЯ МЕТАСТАТИЧЕСКОГО КОЛОРЕКТАЛЬНОГО РАКА У БОЛЬНЫХ С РЕЗЕКТАБЕЛЬНЫМИ МЕТАСТАЗАМИ В …
ДН Костромицкий, АЮ Добродеев, СГ Афанасьев… - elibrary.ru
Изобретение относится к медицине, а именно к онкологии, и может быть использовано
для комбинированного лечения метастатического колоректального рака у больных с …
для комбинированного лечения метастатического колоректального рака у больных с …